However, evidence obtained in mouse models deleting prime p53 target genes or expressing separation-of-function mutants of p53 with defective transcriptional activation but unaltered tumor suppression cast doubts on the exclusiveness of this canonical view (for review see [4]). The gene discussed is TP53; the disease is neoplasm.